News January 31, 2022 Entrepreneurial Development | Seed The SEED Innovator Support Team helps NIH awardees build a business and explore their life… Super User 0 Love0
News January 31, 2022 Cartesian Therapeutics Doses Patient with First Allogeneic RNA Cell Therapy for Multiple Myeloma – Cartesian Gaithersburg, Md., January 25, 2022 – Cartesian Therapeutics, a fully integrated clinical-stage biotechnology company pioneering… Super User 0 Love0
BHI Weekly News Archives January 25, 2022 492nd Edition, January 25, 2022 Trouble Viewing This Email: Click Here January 25, 2022 FOUNDING MEMBER OF Vaccitech CEO Bill… Super User 0 Love0
BHI Weekly News Archives January 25, 2022 491st Edition, January 18, 2022 Trouble Viewing This Email: Click Here January 19, 2022 FOUNDING MEMBER OF BHI Client Avidea Merger… Super User 0 Love0
BHI Weekly News Archives January 25, 2022 490th Edition, January 11, 2022 Trouble Viewing This Email: Click Here January 11, 2022 FOUNDING MEMBER OF Horizon Therapeutics plc Announces… Super User 0 Love0
BHI Weekly News Archives January 25, 2022 489th Edition, January 4, 2022 Trouble Viewing This Email: Click Here January 04, 2022 FOUNDING MEMBER OF BHI Recruiting a Senior… Super User 0 Love0
BHI Weekly News Archives January 25, 2022 488th Edition, December 28, 2021 Trouble Viewing This Email: Click Here December 28, 2021 FOUNDING MEMBER OF Emmes Acquires Institut… Super User 0 Love0
BHI Weekly News Archives January 25, 2022 487th Edition, December 21, 2021 Trouble Viewing This Email: Click Here December 21, 2021 FOUNDING MEMBER OF WBJ: Exclusive: D.C.… Super User 0 Love0
News January 24, 2022 Vaccitech CEO Bill Enright Joins Rich Bendis on First BioTalk of 2022 Bill visits BioTalk to talk about being a serial entrepreneur, biotech executive, and their recent… Super User 0 Love0
BioTalk with Rich Bendis Podcast January 24, 2022 Vaccitech CEO Bill Enright Joins Rich Bendis on First BioTalk of 2022 Bill visits BioTalk to talk about being a serial entrepreneur, biotech executive, and their recent… Super User 0 Love0